+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 147 Pages
  • February 2022
  • Region: Global
  • IMARC Group
  • ID: 5547112
The global next-generation sequencing (NGS) market reached a value of US$ 13.82 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 40.25 Billion by 2027, exhibiting a CAGR of 19.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA. It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. It is a cost-effective solution that offers precise results with high accuracy and speed. This enables the analysis of millions of DNA molecules simultaneously, which facilitates research in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.

Next-Generation Sequencing (NGS) Market Drivers:


The increasing prevalence of chronic medical ailments, such as cancer, along with various technological advancements in the field of medical sciences, is one of the key factors driving the growth of the market. Owing to the widespread adoption of liquid biopsies in cancer diagnostics, there has been a significant increase in the utilization of NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. Furthermore, the increasing adoption of genome mapping programs to predict the development of various diseases is also providing a boost to the market growth. Genetic maps are used for guiding scientists to analyze the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions. Additionally, various technological advancements and integration with the cloud-computing systems for improved data management, are creating a positive impact on the market growth. Other factors, including the declining costs of NGS systems and extensive research and development (R&D) activities in the field of sequencing chemistry, molecular biology and technical engineering, are projected to drive the global next-generation sequencing market further.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global next-generation sequencing (NGS) market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on sequencing type, product type, technology, application and end-user.

Breakup by Sequencing Type:

  • Whole Genome Sequencing
  • Targeted Resequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • CHIP Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
  • Others

Breakup by Product Type:

  • Instruments
  • Reagents and Consumables
  • Software and Services

Breakup by Technology:

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Others

Breakup by Application:

  • Biomarker and Cancer
  • Drug Discovery and Personalized Medicine
  • Genetic Screening
  • Diagnostics
  • Agriculture and Animal Research
  • Others

Breakup by End-User:

  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:


The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Key Questions Answered in this Report

1. What is the expected growth rate of the global next-generation sequencing (NGS) market?
2. What has been the impact of COVID-19 on the global next-generation sequencing (NGS) market?
3. What are the key factors driving the global next-generation sequencing (NGS) market?
4. What is the breakup of the global next-generation sequencing (NGS) market based on the sequencing type?
5. What is the breakup of the global next-generation sequencing (NGS) market based on the product type?
6. What is the breakup of the global next-generation sequencing (NGS) market based on the technology?
7. What is the breakup of the global next-generation sequencing (NGS) market based on the end-user?
8. What is the breakup of the global next-generation sequencing (NGS) market based on the application?
9. What are the key regions in the global next-generation sequencing (NGS) market?
10. Who are the key players/companies in the global next-generation sequencing (NGS) market?
Frequently Asked Questions about the Global Next-Generation Sequencing (NGS) Market

What is the estimated value of the Global Next-Generation Sequencing (NGS) Market?

The Global Next-Generation Sequencing (NGS) Market was estimated to be valued at $13.82 Billion in 2021.

What is the growth rate of the Global Next-Generation Sequencing (NGS) Market?

The growth rate of the Global Next-Generation Sequencing (NGS) Market is 20.3%, with an estimated value of $40.25 Billion by 2027.

What is the forecasted size of the Global Next-Generation Sequencing (NGS) Market?

The Global Next-Generation Sequencing (NGS) Market is estimated to be worth $40.25 Billion by 2027.

Who are the key companies in the Global Next-Generation Sequencing (NGS) Market?

Key companies in the Global Next-Generation Sequencing (NGS) Market include Agilent Technologies, Becton Dickinson, Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann, La Roche AG, Illumina Inc. and Genewiz.

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Next-Generation Sequencing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Sequencing Type
6.1 Whole Genome Sequencing
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Targeted Resequencing
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Whole Exome Sequencing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 RNA Sequencing
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 CHIP Sequencing
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 De Novo Sequencing
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Methyl Sequencing
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Product Type
7.1 Instruments
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Reagents and Consumables
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Software and Services
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Technology
8.1 Sequencing by Synthesis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ion Semiconductor Sequencing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Single-Molecule Real-Time Sequencing
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nanopore Sequencing
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Application
9.1 Biomarker and Cancer
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Drug Discovery and Personalized Medicine
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Genetic Screening
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Diagnostics
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Agriculture and Animal Research
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Others
9.6.1 Market Trends
9.6.2 Market Forecast
10 Market Breakup by End-User
10.1 Academic Institutes & Research Centers
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hospitals & Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Pharmaceutical & Biotechnology Companies
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Agilent Technologies Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Becton Dickinson and Company
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 10x Genomics
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 BGI Group
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Eurofins Scientific
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 F. Hoffmann-La Roche AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Illumina Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Genewiz
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Macrogen Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 Oxford Nanopore Technologies
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Pacific Biosciences
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 Perkinelmer Inc.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Thermo Fisher Scientific Inc.
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
16.3.13.4 SWOT Analysis
16.3.14 Qiagen N.V.
16.3.14.1 Company Overview
16.3.14.2 Product Portfolio
16.3.14.3 Financials
16.3.14.4 SWOT Analysis
16.3.15 Genapsys Inc.
16.3.15.1 Company Overview
16.3.15.2 Product Portfolio
List of Figures
Figure 1: Global: Next-Generation Sequencing Market: Major Drivers and Challenges
Figure 2: Global: Next-Generation Sequencing Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Next-Generation Sequencing Market: Breakup by Sequencing Type (in %), 2021
Figure 4: Global: Next-Generation Sequencing Market: Breakup by Product Type (in %), 2021
Figure 5: Global: Next-Generation Sequencing Market: Breakup by Technology (in %), 2021
Figure 6: Global: Next-Generation Sequencing Market: Breakup by Application (in %), 2021
Figure 7: Global: Next-Generation Sequencing Market: Breakup by End-User (in %), 2021
Figure 8: Global: Next-Generation Sequencing Market: Breakup by Region (in %), 2021
Figure 9: Global: Next-Generation Sequencing Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 10: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Next-Generation Sequencing (Targeted Resequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Next-Generation Sequencing (Targeted Resequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Next-Generation Sequencing (RNA Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Next-Generation Sequencing (RNA Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Next-Generation Sequencing (CHIP Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Next-Generation Sequencing (CHIP Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Next-Generation Sequencing (De Novo Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Next-Generation Sequencing (De Novo Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Next-Generation Sequencing (Methyl Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Next-Generation Sequencing (Methyl Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Next-Generation Sequencing (Other Sequencing Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Next-Generation Sequencing (Other Sequencing Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Next-Generation Sequencing (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Next-Generation Sequencing (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Next-Generation Sequencing (Reagents and Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Next-Generation Sequencing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Next-Generation Sequencing (Software and Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Next-Generation Sequencing (Software and Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Next-Generation Sequencing (Nanopore Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Next-Generation Sequencing (Nanopore Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Next-Generation Sequencing (Biomarker and Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Next-Generation Sequencing (Biomarker and Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Global: Next-Generation Sequencing (Genetic Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Global: Next-Generation Sequencing (Genetic Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Global: Next-Generation Sequencing (Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Global: Next-Generation Sequencing (Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Global: Next-Generation Sequencing (Hospitals & Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Global: Next-Generation Sequencing (Hospitals & Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: North America: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: North America: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: United States: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: United States: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Canada: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Canada: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Asia Pacific: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Asia Pacific: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: China: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: China: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Japan: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Japan: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: India: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: India: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: South Korea: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: South Korea: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Australia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Australia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Indonesia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Indonesia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Europe: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Europe: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Germany: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Germany: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: France: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: France: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: United Kingdom: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: United Kingdom: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Italy: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Italy: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Spain: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 95: Spain: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Russia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 97: Russia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 98: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 99: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 100: Latin America: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 101: Latin America: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 102: Brazil: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 103: Brazil: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 104: Mexico: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 105: Mexico: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 106: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 107: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 108: Middle East and Africa: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 109: Middle East and Africa: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 110: Global: Next-Generation Sequencing Industry: SWOT Analysis
Figure 111: Global: Next-Generation Sequencing Industry: Value Chain Analysis
Figure 112: Global: Next-Generation Sequencing Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Next-Generation Sequencing Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Next-Generation Sequencing Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Next-Generation Sequencing Market Forecast: Breakup by Sequencing Type (in Million US$), 2022-2027
Table 4: Global: Next-Generation Sequencing Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 5: Global: Next-Generation Sequencing Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Next-Generation Sequencing Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 7: Global: Next-Generation Sequencing Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: Next-Generation Sequencing Market Structure
Table 9: Global: Next-Generation Sequencing Market: Key Players

Companies Mentioned

  • Agilent Technologies
  • Becton Dickinson
  • Company
  • 10x Genomics
  • BGI Group
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Illumina Inc.
  • Genewiz
  • Macrogen
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • PerkinElmer
  • Thermo Fisher Scientific
  • Qiagen N.V.
  • GenapSys Inc.

Methodology

Loading
LOADING...